US Stock MarketDetailed Quotes

IGMS IGM Biosciences

Watchlist

11.500
+0.110+0.97%

Trading Sep 13 12:09 ET

682.16MMarket Cap-3221P/E (TTM)

IGM Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

29.62%-37.37M

16.82%-42.42M

-3,184.32%-192.23M

-26.81%-48.01M

0.72%-40.12M

-147.71%-53.11M

-31.13%-51M

95.32%-5.85M

-7.25%-37.86M

-17.46%-40.41M

Net income from continuing operations

25.64%-47.9M

16.01%-49.82M

-11.45%-246.42M

-15.44%-60.7M

-6.81%-61.99M

-9.95%-64.42M

-14.29%-59.31M

-33.87%-221.1M

-3.82%-52.58M

-31.41%-58.04M

Depreciation and amortization

4.74%2.28M

30.77%2.18M

36.25%8.28M

14.91%2.18M

49.70%2.26M

50.48%2.17M

35.95%1.66M

35.48%6.08M

45.66%1.9M

37.81%1.51M

Other non cash items

-14.60%2.56M

-15.85%2.55M

26.54%15.19M

-27.37%3.9M

81.83%5.26M

8.73%3M

208.66%3.03M

335.98%12.01M

739.22%5.37M

128.13%2.9M

Change In working capital

84.69%-896K

39.60%-2.98M

-104.31%-6.69M

61.57%-643K

42.69%4.74M

-103.79%-5.85M

-471.76%-4.94M

2,306.86%155.17M

-135.50%-1.67M

223.35%3.32M

-Change in prepaid assets

85.30%-529K

1,801.72%987K

376.60%1.71M

509.75%1.64M

274.82%3.73M

-283.72%-3.6M

-106.22%-58K

110.89%359K

75.08%-400K

-1,677.50%-2.13M

-Change in payables and accrued expense

273.53%2.27M

-13.87%-3.98M

-139.30%-4.21M

-567.92%-1.06M

-79.12%1.66M

-134.50%-1.31M

-296.60%-3.5M

-19.05%10.7M

-102.20%-159K

300.00%7.96M

-Change in other current assets

357.89%174K

232.47%204K

120.06%194K

45.00%174K

112.11%136K

442.86%38K

-631.03%-154K

-98.16%-967K

195.24%120K

-1,321.52%-1.12M

-Change in other current liabilities

-189.57%-1.56M

143.08%305K

41.34%-2.26M

13.81%-743K

73.78%-274K

46.57%-537K

25.00%-708K

-29.05%-3.86M

-10.51%-862K

-37.14%-1.05M

-Change in other working capital

-179.91%-1.25M

4.79%-497K

-101.43%-2.13M

-75.00%-651K

-53.78%-509K

---448K

---522K

--148.93M

---372K

---331K

Cash from discontinued investing activities

Operating cash flow

29.62%-37.37M

16.82%-42.42M

-3,184.32%-192.23M

-26.81%-48.01M

0.72%-40.12M

-147.71%-53.11M

-31.13%-51M

95.32%-5.85M

-7.25%-37.86M

-17.46%-40.41M

Investing cash flow

Cash flow from continuing investing activities

487.73%24.52M

-87.61%8.65M

130.29%68.36M

21.89%-14.69M

621.58%19.55M

96.56%-6.33M

465.51%69.82M

-1,559.44%-225.64M

-939.78%-18.81M

92.04%-3.75M

Net PPE purchase and sale

69.79%-1.18M

36.91%-2.48M

-21.31%-12.38M

46.27%-1.45M

-13.72%-3.08M

-114.65%-3.91M

-32.25%-3.94M

22.94%-10.21M

-52.86%-2.7M

-20.70%-2.71M

Net investment purchase and sale

1,165.75%25.71M

-84.90%11.14M

137.48%80.74M

17.81%-13.25M

2,282.45%22.63M

98.68%-2.41M

557.40%73.76M

-850.52%-215.44M

-502.60%-16.12M

97.69%-1.04M

Cash from discontinued investing activities

Investing cash flow

487.73%24.52M

-87.61%8.65M

130.29%68.36M

21.89%-14.69M

621.58%19.55M

96.56%-6.33M

465.51%69.82M

-1,559.44%-225.64M

-939.78%-18.81M

92.04%-3.75M

Financing cash flow

Cash flow from continuing financing activities

-99.12%615K

102.67%152K

-47.55%115.07M

-16.60%402K

14,929.97%44.64M

-67.99%69.95M

4.17%75K

8,760.34%219.38M

-67.67%482K

-72.27%297K

Net common stock issuance

----

-47.90%113.56M

--0

--44.62M

----

--217.99M

--0

Proceeds from stock option exercised by employees

-35.52%648K

154.67%191K

7.81%1.5M

-16.60%402K

-92.59%22K

108.07%1.01M

-43.61%75K

-65.39%1.4M

-70.39%482K

-79.85%297K

Net other financing activities

---33K

---39K

----

Cash from discontinued financing activities

Financing cash flow

-99.12%615K

102.67%152K

-47.55%115.07M

-16.60%402K

14,929.97%44.64M

-67.99%69.95M

4.17%75K

8,760.34%219.38M

-67.67%482K

-72.27%297K

Net cash flow

Beginning cash position

-43.55%79.5M

-7.22%113.11M

-9.04%121.92M

-1.51%175.41M

-31.82%151.34M

85.01%140.82M

-9.04%121.92M

-44.40%134.04M

7.55%178.11M

-9.79%221.97M

Current changes in cash

-216.28%-12.24M

-277.83%-33.61M

27.30%-8.81M

-10.88%-62.3M

154.87%24.07M

-92.79%10.52M

132.63%18.9M

88.68%-12.12M

-77.98%-56.19M

45.47%-43.86M

End cash Position

-55.56%67.26M

-43.55%79.5M

-7.22%113.11M

-1.51%175.41M

-31.82%151.34M

85.01%140.82M

-9.04%121.92M

7.55%178.11M

Free cash flow

32.32%-38.59M

18.26%-44.9M

-1,174.13%-204.61M

-21.95%-49.46M

-0.19%-43.2M

-152.08%-57.02M

-31.21%-54.93M

88.38%-16.06M

-9.42%-40.55M

-17.66%-43.12M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	29.62%-37.37M	16.82%-42.42M	-3,184.32%-192.23M	-26.81%-48.01M	0.72%-40.12M	-147.71%-53.11M	-31.13%-51M	95.32%-5.85M	-7.25%-37.86M	-17.46%-40.41M
Net income from continuing operations	25.64%-47.9M	16.01%-49.82M	-11.45%-246.42M	-15.44%-60.7M	-6.81%-61.99M	-9.95%-64.42M	-14.29%-59.31M	-33.87%-221.1M	-3.82%-52.58M	-31.41%-58.04M
Depreciation and amortization	4.74%2.28M	30.77%2.18M	36.25%8.28M	14.91%2.18M	49.70%2.26M	50.48%2.17M	35.95%1.66M	35.48%6.08M	45.66%1.9M	37.81%1.51M
Other non cash items	-14.60%2.56M	-15.85%2.55M	26.54%15.19M	-27.37%3.9M	81.83%5.26M	8.73%3M	208.66%3.03M	335.98%12.01M	739.22%5.37M	128.13%2.9M
Change In working capital	84.69%-896K	39.60%-2.98M	-104.31%-6.69M	61.57%-643K	42.69%4.74M	-103.79%-5.85M	-471.76%-4.94M	2,306.86%155.17M	-135.50%-1.67M	223.35%3.32M
-Change in prepaid assets	85.30%-529K	1,801.72%987K	376.60%1.71M	509.75%1.64M	274.82%3.73M	-283.72%-3.6M	-106.22%-58K	110.89%359K	75.08%-400K	-1,677.50%-2.13M
-Change in payables and accrued expense	273.53%2.27M	-13.87%-3.98M	-139.30%-4.21M	-567.92%-1.06M	-79.12%1.66M	-134.50%-1.31M	-296.60%-3.5M	-19.05%10.7M	-102.20%-159K	300.00%7.96M
-Change in other current assets	357.89%174K	232.47%204K	120.06%194K	45.00%174K	112.11%136K	442.86%38K	-631.03%-154K	-98.16%-967K	195.24%120K	-1,321.52%-1.12M
-Change in other current liabilities	-189.57%-1.56M	143.08%305K	41.34%-2.26M	13.81%-743K	73.78%-274K	46.57%-537K	25.00%-708K	-29.05%-3.86M	-10.51%-862K	-37.14%-1.05M
-Change in other working capital	-179.91%-1.25M	4.79%-497K	-101.43%-2.13M	-75.00%-651K	-53.78%-509K	---448K	---522K	--148.93M	---372K	---331K
Cash from discontinued investing activities
Operating cash flow	29.62%-37.37M	16.82%-42.42M	-3,184.32%-192.23M	-26.81%-48.01M	0.72%-40.12M	-147.71%-53.11M	-31.13%-51M	95.32%-5.85M	-7.25%-37.86M	-17.46%-40.41M
Investing cash flow
Cash flow from continuing investing activities	487.73%24.52M	-87.61%8.65M	130.29%68.36M	21.89%-14.69M	621.58%19.55M	96.56%-6.33M	465.51%69.82M	-1,559.44%-225.64M	-939.78%-18.81M	92.04%-3.75M
Net PPE purchase and sale	69.79%-1.18M	36.91%-2.48M	-21.31%-12.38M	46.27%-1.45M	-13.72%-3.08M	-114.65%-3.91M	-32.25%-3.94M	22.94%-10.21M	-52.86%-2.7M	-20.70%-2.71M
Net investment purchase and sale	1,165.75%25.71M	-84.90%11.14M	137.48%80.74M	17.81%-13.25M	2,282.45%22.63M	98.68%-2.41M	557.40%73.76M	-850.52%-215.44M	-502.60%-16.12M	97.69%-1.04M
Cash from discontinued investing activities
Investing cash flow	487.73%24.52M	-87.61%8.65M	130.29%68.36M	21.89%-14.69M	621.58%19.55M	96.56%-6.33M	465.51%69.82M	-1,559.44%-225.64M	-939.78%-18.81M	92.04%-3.75M
Financing cash flow
Cash flow from continuing financing activities	-99.12%615K	102.67%152K	-47.55%115.07M	-16.60%402K	14,929.97%44.64M	-67.99%69.95M	4.17%75K	8,760.34%219.38M	-67.67%482K	-72.27%297K
Net common stock issuance	----	----	-47.90%113.56M	--0	--44.62M	----	----	--217.99M	--0	--0
Proceeds from stock option exercised by employees	-35.52%648K	154.67%191K	7.81%1.5M	-16.60%402K	-92.59%22K	108.07%1.01M	-43.61%75K	-65.39%1.4M	-70.39%482K	-79.85%297K
Net other financing activities	---33K	---39K	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-99.12%615K	102.67%152K	-47.55%115.07M	-16.60%402K	14,929.97%44.64M	-67.99%69.95M	4.17%75K	8,760.34%219.38M	-67.67%482K	-72.27%297K
Net cash flow
Beginning cash position	-43.55%79.5M	-7.22%113.11M	-9.04%121.92M	-1.51%175.41M	-31.82%151.34M	85.01%140.82M	-9.04%121.92M	-44.40%134.04M	7.55%178.11M	-9.79%221.97M
Current changes in cash	-216.28%-12.24M	-277.83%-33.61M	27.30%-8.81M	-10.88%-62.3M	154.87%24.07M	-92.79%10.52M	132.63%18.9M	88.68%-12.12M	-77.98%-56.19M	45.47%-43.86M
End cash Position	-55.56%67.26M	-43.55%79.5M	-7.22%113.11M	-7.22%113.11M	-1.51%175.41M	-31.82%151.34M	85.01%140.82M	-9.04%121.92M	-9.04%121.92M	7.55%178.11M
Free cash flow	32.32%-38.59M	18.26%-44.9M	-1,174.13%-204.61M	-21.95%-49.46M	-0.19%-43.2M	-152.08%-57.02M	-31.21%-54.93M	88.38%-16.06M	-9.42%-40.55M	-17.66%-43.12M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data